Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
ysjWsVtPQczVh9Z6